SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-003182
Filing Date
2022-01-31
Accepted
2022-01-31 07:32:53
Documents
15
Period of Report
2022-01-24
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10033283_8k.htm   iXBRL 8-K 26702
2 EXHIBIT 99.1 brhc10033283_ex99-1.htm EX-99.1 22962
6 image00001.jpg GRAPHIC 3206
7 image00002.jpg GRAPHIC 3857
  Complete submission text file 0001140361-22-003182.txt   202562

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20220124.xsd EX-101.SCH 3932
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20220124_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20220124_pre.xml EX-101.PRE 16048
9 EXTRACTED XBRL INSTANCE DOCUMENT brhc10033283_8k_htm.xml XML 4072
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 22571346
SIC: 2834 Pharmaceutical Preparations